- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about MDT
Recent news which mentions MDT
Is Intuitive Surgical Stock a Buy Now?
April 26, 2022
From Motley Fool
From Motley Fool
2 Top Stocks to Buy in April and Hold Forever
April 16, 2022
From Motley Fool
From Motley Fool
This is what you should do in the stock market now, according to three 2022 fund-award winners
April 07, 2022
From MarketWatch
3 Healthcare Stocks You Can Buy and Hold for the Next Decade
April 06, 2022
From Motley Fool
7 Medical Device Stocks to Buy as Covid-19 Fears Fade
April 05, 2022
From InvestorPlace
From Motley Fool
3 Top Healthcare ETFs to Buy Now and Hold for the Long Haul
March 31, 2022
From Motley Fool
3 Unstoppable Stocks to Buy in a Bear Market
March 30, 2022
From Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
March 18, 2022
From Benzinga
Better Buy: Intuitive Surgical vs. Medtronic
March 17, 2022
From Motley Fool
Medtronic's US Trial Of GI Genius Endoscopy Module Reduces Missed Colorectal Polyps By 50%
March 16, 2022
Tickers
MDT
From Benzinga
Biden to meet with CEOs of Micron, HP, Medtronic in push for spending on chip manufacturing
March 09, 2022
From MarketWatch
2 Cheap Dividend Stocks Near Their 52-Week Lows
March 09, 2022
From Motley Fool
Inspira Technologies, The Company That Aims To Change 50 Years Of Therapeutic Paradigm In Patients With Respiratory Failure
March 07, 2022
From Benzinga
From Benzinga
From Motley Fool
3 Supercharged Stocks to Buy With $1,000 Right Now
March 02, 2022
From Motley Fool
10 Biggest Price Target Changes For Wednesday
February 23, 2022
From Benzinga
FDA Approves Medtronic's Recharge-Free Sacral Nerve Stimulation Therapy For Bladder, Bowel Control
February 23, 2022
Tickers
MDT
From Benzinga
From Benzinga
Investors Give, Then Take Away, in Meihua's New York Trading Debut
February 22, 2022
From Benzinga
Medtronic's Q3 Profit In Line With Expectation Despite COVID-19 Impact On Procedure Volume
February 22, 2022
Tickers
MDT
From Benzinga
3 Stocks to Buy as Investors Double Down on Digital Health
February 22, 2022
From InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.